Will Johnson & Johnson (JNJ) Q3 Innovative Medicine revenue be above __?
Will Johnson & Johnson (JNJ) Q3 Innovative Medicine revenue be above __?
13 жовт. 2026 р.
$3.09K Vol.
Will Johnson & Johnson (JNJ) Q3 Innovative Medicine revenue be above __?
End date: 13 жовт. 2026 р.
Outcomes
$16.6B
$211.88 Vol.
45%
45%
$16.8B
$181.63 Vol.
40%
40%
$17B
$118.98 Vol.
33%
33%
$17.2B
$2.14K Vol.
28%
28%
$17.4B
$544.6 Vol.
29%
29%
Rules
This market will resolve to "Yes" if Johnson & Johnson's Innovative Medicine revenue for the upcoming third fiscal quarter, as reported in its official company earnings materials, is above the listed amount. Otherwise, this market will resolve to "No".
Comments
Comments